James T Kearns1, Daniel W Lin2,3. 1. Department of Urology, University of Washington School of Medicine, 1959 NE Pacific, Box 356510, Seattle, WA, 98195, USA. jkearns1@uw.edu. 2. Department of Urology, University of Washington School of Medicine, 1959 NE Pacific, Box 356510, Seattle, WA, 98195, USA. 3. Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Abstract
PURPOSE OF REVIEW: Prostate cancer remains a significant public health burden. In order to decrease the morbidity and mortality associated with prostate cancer, serum prostate-specific antigen (PSA) screening has been used since the 1990s. However, there is concern for overdiagnosis of prostate cancer with widespread PSA screening, which could lead to overtreatment and its attendant morbidities. RECENT FINDINGS: In order to avoid unnecessary biopsy and downstream effects including treatment of insignificant prostate cancer, a number of tests have been proposed to improve upon PSA screening. Increasing the specificity of prostate cancer screening above that of PSA testing should reduce the incidence of unnecessary prostate biopsy. However, an increase in specificity is associated with a decrease in sensitivity, so these tests must be balanced with the concern for missing the diagnosis of potentially significant disease. In this context, we present a review of six common biomarkers proposed to improve the specificity of prostate cancer screening-free PSA, prostate health index, 4Kscore, PCA3, Select MDx, and ExoDx Prostate(Intelliscore).
PURPOSE OF REVIEW: Prostate cancer remains a significant public health burden. In order to decrease the morbidity and mortality associated with prostate cancer, serum prostate-specific antigen (PSA) screening has been used since the 1990s. However, there is concern for overdiagnosis of prostate cancer with widespread PSA screening, which could lead to overtreatment and its attendant morbidities. RECENT FINDINGS: In order to avoid unnecessary biopsy and downstream effects including treatment of insignificant prostate cancer, a number of tests have been proposed to improve upon PSA screening. Increasing the specificity of prostate cancer screening above that of PSA testing should reduce the incidence of unnecessary prostate biopsy. However, an increase in specificity is associated with a decrease in sensitivity, so these tests must be balanced with the concern for missing the diagnosis of potentially significant disease. In this context, we present a review of six common biomarkers proposed to improve the specificity of prostate cancer screening-free PSA, prostate health index, 4Kscore, PCA3, Select MDx, and ExoDx Prostate(Intelliscore).
Entities:
Keywords:
Biomarkers; PSA screening; Prostate cancer
Authors: Aaron A Laviana; Annette M Ilg; Darlene Veruttipong; Hung-Jui Tan; Michael A Burke; Douglas R Niedzwiecki; Patrick A Kupelian; Chris R King; Michael L Steinberg; Chandan R Kundavaram; Mitchell Kamrava; Alan L Kaplan; Andrew K Moriarity; William Hsu; Daniel J A Margolis; Jim C Hu; Christopher S Saigal Journal: Cancer Date: 2015-11-02 Impact factor: 6.860
Authors: Ina L Deras; Sheila M J Aubin; Amy Blase; John R Day; Seongjoon Koo; Alan W Partin; William J Ellis; Leonard S Marks; Yves Fradet; Harry Rittenhouse; Jack Groskopf Journal: J Urol Date: 2008-03-04 Impact factor: 7.450
Authors: W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick Journal: JAMA Date: 1998-05-20 Impact factor: 56.272
Authors: Stacy Loeb; Sanghyuk S Shin; Dennis L Broyles; John T Wei; Martin Sanda; George Klee; Alan W Partin; Lori Sokoll; Daniel W Chan; Chris H Bangma; Ron H N van Schaik; Kevin M Slawin; Leonard S Marks; William J Catalona Journal: BJU Int Date: 2016-11-22 Impact factor: 5.588
Authors: Andrew Vickers; Angel Cronin; Monique Roobol; Caroline Savage; Mari Peltola; Kim Pettersson; Peter T Scardino; Fritz Schröder; Hans Lilja Journal: J Clin Oncol Date: 2010-04-26 Impact factor: 44.544
Authors: Stacy Loeb; Martin G Sanda; Dennis L Broyles; Sanghyuk S Shin; Chris H Bangma; John T Wei; Alan W Partin; George G Klee; Kevin M Slawin; Leonard S Marks; Ron H N van Schaik; Daniel W Chan; Lori J Sokoll; Amabelle B Cruz; Isaac A Mizrahi; William J Catalona Journal: J Urol Date: 2014-11-15 Impact factor: 7.450
Authors: M J Bussemakers; A van Bokhoven; G W Verhaegh; F P Smit; H F Karthaus; J A Schalken; F M Debruyne; N Ru; W B Isaacs Journal: Cancer Res Date: 1999-12-01 Impact factor: 12.701
Authors: William J Catalona; Jerome P Richie; Frederick R Ahmann; M'Liss A Hudson; Peter T Scardino; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick Journal: J Urol Date: 1994-05 Impact factor: 7.450
Authors: A Gupta; M J Roobol; C J Savage; M Peltola; K Pettersson; P T Scardino; A J Vickers; F H Schröder; H Lilja Journal: Br J Cancer Date: 2010-07-27 Impact factor: 7.640
Authors: Andrew J Vickers; Angel M Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Becker; Kim Pettersson; Peter T Scardino; Jonas Hugosson; Hans Lilja Journal: BMC Med Date: 2008-07-08 Impact factor: 8.775
Authors: Ana Rita Lima; Joana Pinto; Carina Carvalho-Maia; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho Journal: Cancers (Basel) Date: 2020-07-23 Impact factor: 6.639
Authors: Yuqian Gao; Yi-Ting Wang; Yongmei Chen; Hui Wang; Denise Young; Tujin Shi; Yingjie Song; Athena A Schepmoes; Claire Kuo; Thomas L Fillmore; Wei-Jun Qian; Richard D Smith; Sudhir Srivastava; Jacob Kagan; Albert Dobi; Isabell A Sesterhenn; Inger L Rosner; Gyorgy Petrovics; Karin D Rodland; Shiv Srivastava; Jennifer Cullen; Tao Liu Journal: Cancers (Basel) Date: 2020-05-17 Impact factor: 6.639
Authors: Ana Rita Lima; Joana Pinto; Ana Isabel Azevedo; Daniela Barros-Silva; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Paula Guedes de Pinho; Márcia Carvalho Journal: Br J Cancer Date: 2019-10-07 Impact factor: 7.640
Authors: Ana Rita Lima; Joana Pinto; Filipa Amaro; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho Journal: Metabolites Date: 2021-03-19